Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Eisen

Showing results (21-30 of 116) with videos related to

Pageof 12
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2006
Role of cytokine therapy in 2006 and beyond for metastatic renal cell cancerMarina Parton, Martin Gore, Tim Eisen
Experimental Dermatology|March 4, 2008
Systemic therapy for metastatic malignant melanoma--from deeply disappointing to bright future?Paul Lorigan, Tim Eisen, Axel Hauschild
Current Oncology Reports|January 22, 2013
Regorafenib (BAY 73-4506): stromal and oncogenic multikinase inhibitor with potential activity in renal cell carcinomaKamarul Zaki, Shahzeena Aslam, Tim Eisen
BMC Cancer|August 22, 2008
Identification of low penetrance alleles for lung cancer: the GEnetic Lung CAncer Predisposition Study (GELCAPS)Tim Eisen, Athena Matakidou, Richard Houlston, et al.
Nature Reviews. Cancer|December 24, 2014
VHL, the story of a tumour suppressor geneLucy Gossage, Tim Eisen, Eamonn R Maher
Expert Review of Anticancer Therapy|December 4, 2009
Impact of anti-angiogenic treatments on metastatic renal cell carcinomaNicola L Ainsworth, Jean Sz Lee, Tim Eisen
Current Oncology Reports|January 22, 2014
Naptumomab estafenatox: targeted immunotherapy with a novel immunotoxinTim Eisen, Gunnar Hedlund, Göran Forsberg, et al.
British Journal of Hospital Medicine (London, England : 2005)|May 20, 2009
UK guidelines for the systemic treatment of renal cell carcinomaPaul Nathan, John Wagstaff, Emilio Porfiri, et al.
BJU International|November 17, 2010
A new patient-focused approach to the treatment of metastatic renal cell carcinoma: establishing customized treatment optionsJoaquim Bellmunt, Tim Eisen, Cezary Szczylik, et al.
Cancer Treatment Reviews|October 13, 2009
Treating the individual: The need for a patient-focused approach to the management of renal cell carcinomaCamillo Porta, Joaquim Bellmunt, Tim Eisen, et al.
Pageof 12

Showing results (21-30 of 116) with videos related to

Sort By:
Pageof 12
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2006
Role of cytokine therapy in 2006 and beyond for metastatic renal cell cancerMarina Parton, Martin Gore, Tim Eisen
Experimental Dermatology|March 4, 2008
Systemic therapy for metastatic malignant melanoma--from deeply disappointing to bright future?Paul Lorigan, Tim Eisen, Axel Hauschild
Current Oncology Reports|January 22, 2013
Regorafenib (BAY 73-4506): stromal and oncogenic multikinase inhibitor with potential activity in renal cell carcinomaKamarul Zaki, Shahzeena Aslam, Tim Eisen
BMC Cancer|August 22, 2008
Identification of low penetrance alleles for lung cancer: the GEnetic Lung CAncer Predisposition Study (GELCAPS)Tim Eisen, Athena Matakidou, Richard Houlston, et al.
Nature Reviews. Cancer|December 24, 2014
VHL, the story of a tumour suppressor geneLucy Gossage, Tim Eisen, Eamonn R Maher
Expert Review of Anticancer Therapy|December 4, 2009
Impact of anti-angiogenic treatments on metastatic renal cell carcinomaNicola L Ainsworth, Jean Sz Lee, Tim Eisen
Current Oncology Reports|January 22, 2014
Naptumomab estafenatox: targeted immunotherapy with a novel immunotoxinTim Eisen, Gunnar Hedlund, Göran Forsberg, et al.
British Journal of Hospital Medicine (London, England : 2005)|May 20, 2009
UK guidelines for the systemic treatment of renal cell carcinomaPaul Nathan, John Wagstaff, Emilio Porfiri, et al.
BJU International|November 17, 2010
A new patient-focused approach to the treatment of metastatic renal cell carcinoma: establishing customized treatment optionsJoaquim Bellmunt, Tim Eisen, Cezary Szczylik, et al.
Cancer Treatment Reviews|October 13, 2009
Treating the individual: The need for a patient-focused approach to the management of renal cell carcinomaCamillo Porta, Joaquim Bellmunt, Tim Eisen, et al.
Pageof 12